Mannan-binding lectin

Mannan-binding lectin (MBL), also known as mannose-binding lectin, is a C-type lectin that plays a significant role in the innate immune system. It is a protein that binds to specific sugars on the surface of pathogens, including bacteria, viruses, and fungi, facilitating their recognition and elimination by the immune system. MBL is part of the lectin pathway of the complement system, which is a crucial mechanism for defending against pathogens without the need for prior exposure.

Structure and Function

MBL is a soluble protein composed of subunits that form a structure resembling a bouquet. Each subunit consists of a carbohydrate recognition domain (CRD) that can bind to mannose and N-acetylglucosamine on the surface of many pathogens. Upon binding to these sugars, MBL activates the complement system via the lectin pathway, leading to the opsonization, lysis, or phagocytosis of the pathogen.

Genetics

The gene encoding MBL is located on chromosome 10 in humans. Variations in this gene can lead to differences in MBL levels and functional activity in the bloodstream, influencing an individual's susceptibility to infections and autoimmune diseases. Low levels of MBL are associated with increased risk of infections, particularly in young children and immunocompromised individuals.

Clinical Significance

MBL deficiency is one of the most common immunodeficiencies, affecting approximately 5-10% of the population. Individuals with low levels of MBL may have an increased susceptibility to infections, especially in situations where the adaptive immune system is not fully developed or is compromised. MBL deficiency has been linked to a variety of conditions, including recurrent respiratory infections, sepsis, and certain autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus (SLE).

Therapeutic Applications

Given its role in innate immunity, there is interest in the therapeutic potential of MBL. Supplementation of MBL in individuals with deficiency is being explored as a treatment to reduce the risk of infections. Additionally, the ability of MBL to recognize and bind to a wide range of pathogens makes it a target for the development of broad-spectrum antimicrobial therapies.

Research Directions

Research on MBL continues to uncover its roles beyond the initial defense against pathogens. Studies are investigating its involvement in modulating inflammatory responses, its potential impact on the progression of chronic diseases, and its role in tissue repair and regeneration.